Cargando…
Molecular Classification of Medulloblastoma
Medulloblastoma (MB) is one of the most frequent malignant brain tumors in children. The current standard treatment regimen consists of surgical resection, craniospinal irradiation, and adjuvant chemotherapy. Although these treatments have the potential to increase the survival of 70–80% of patients...
Autores principales: | KIJIMA, Noriyuki, KANEMURA, Yonehiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221779/ https://www.ncbi.nlm.nih.gov/pubmed/27238212 http://dx.doi.org/10.2176/nmc.ra.2016-0016 |
Ejemplares similares
-
MBRS-38. MOLECULAR CLASSIFICATION AND CLINICAL CHARACTERISTICS OF 236 MEDULLOBLASTOMAS IN JAPAN
por: Kanemura, Yonehiro, et al.
Publicado: (2020) -
Molecular Biology of Pediatric Hydrocephalus and Hydrocephalus-related Diseases
por: YAMASAKI, Mami, et al.
Publicado: (2015) -
MPC-02 REVIEW OF MEDULLOBLASTOMA FOR THE ASSESSMENT OF CONSENSUS IN PATHOLOGICAL DIAGNOSIS USING JPMNG CASES
por: Sasaki, Atsushi, et al.
Publicado: (2019) -
Medulloblastoma: molecular pathways and histopathological classification
por: Borowska, Anna, et al.
Publicado: (2016) -
Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery
por: Srinivasan, Visish M., et al.
Publicado: (2016)